Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) has shared an announcement.
Modern Chinese Medicine Group Co., Ltd. reported a 15.4% decrease in revenue to RMB64.8 million for the first half of 2025 compared to the previous year. Despite the revenue decline, the company turned its financial performance around, achieving a profit of RMB2.5 million compared to a loss of RMB6.9 million in the same period last year, indicating improved cost management and operational efficiency.
The most recent analyst rating on (HK:1643) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Modern Chinese Medicine Group Co. Ltd. stock, see the HK:1643 Stock Forecast page.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. operates in the traditional Chinese medicine industry, focusing on the production and distribution of Chinese medicinal products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 1,667,906
Technical Sentiment Signal: Buy
Current Market Cap: HK$518.4M
Learn more about 1643 stock on TipRanks’ Stock Analysis page.